Our data provide evidence that an AID designed to promote GB integrity and function is capable to prevent occurrence of T1D by improving mucus layer architecture and composition and promoting immune tolerance, i.e., FoxP3+ Treg and IL-10+ Tr1 expansion, in the intestine but also in PLN and islets of NOD mice. This evidence concerns the gene FOXP3 and type 1 diabetes mellitus.